Uterine adenomatoid tumors: Immunohistochemical characteristics with emphasis on Ber-EP4 immunoreactivity and distinction from adenocarcinoma

International Journal of Gynecological Pathology

Volumn 15, Issue 2, 1996, Pages 146-151

  Otis, Christopher N ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Baystate Med Cent   (United States)

Author keywords

Ber EP4; Immunohistochemistry; Pelviscopy; Uterine adenomatoid tumor

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD15 ANTIGEN;

ADENOCARCINOMA; ADENOMATOID TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MESOTHELIUM CELL; METASTASIS; PRIORITY JOURNAL; UTERUS TUMOR;

EID: 0030002861     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199604000-00009     Document Type: Article

References (26)

1. Golden A, Ash J. Adenomatoid tumors of the genital tract. Am J Pathol 1944;2:63-79.
2. Marcus J, Lynn J. Ultrastructural comparison of an adenomatoid tumor, lymphangioma, hemangioma, and mesothelioma. Cancer 1970;25:171-5.
3. Quigley J, Hart W. Adenomatoid tumors of the uterus. Am J Clin Pathol 1981;76:627-35.
4. Taxy J, Battifora H, Oyasu R. Adenomatoid tumors: a light microscopic, histochemical and ultrastructural study. Cancer 1974;34:306-16.
5. Ferenczy A, Fenoglio J, Richart R. Observations on benign mesothelioma of the genital tract (adenomatoid tumor). Cancer 1972;30:244-60.
6. Davy C, Tang C. Are all adenomatoid tumors adenomatoid mesotheliomas? Hum Pathol 1981;12:360-9.
7. Mackay B, Bennington J, Skoglund R. The adenomatoid tumor: fine structural evidence for a mesothelial origin. Cancer 1971;27:109-15.
8. Salazar H, Kanbour A, Burgess F. Ultrastructure and observations on the histogenesis of mesotheliomas, "adenomatoid tumors," of the female genital tract. Cancer 1972;29: 141-52.
9. Sidhu G, Fresko O. Adenomatoid tumor of the epididymis: ultrastructural evidence of its biphasic nature. Ultrastruct Pathol 1980;1:39-17.
10. Youngs L, Taylor H. Adenomatoid tumors of the uterus and fallopian tube. Am J Clin Pathol 1967;48:537-45.
11. Bell D, Flotte T. Factor VIII related antigen in adenomatoid tumors: implications for histogenesis. Cancer 1982;50:932-8.
12. Barwick K, Madri J. An immunohistochemical study of adenomatoid tumors utilizing keratin and factor VIII antibodies: evidence for mesothelial origin. Lab Invest 1982;47:276- 90.
13. Lento V, Miettinen M, Virtanen I. Adenomatoid tumor: immunohistochemical features suggesting a mesothelial origin. Virchows Arch [B] 1983;42:153-9.
14. Said J, Nash G, Lee M. Immunoperoxidase localization of keratin proteins, carcinoembryonic antigen, and factor VIII in adenomatoid tumors: evidence for a mesothelial derivation. Hum Pathol 1982;13:1106-8.
15. Stephenson T, Mills P. Adenomatoid tumors: an immunohistochemical and ultrastructural appraisal of their histogenesis. J Pathol 1986;148:327-35.
16. Wood C, Bouchell W. Benign mesothelioma simulating a uterine leiomyoma. Am J Obstet Gynecol 1978;132:225-6.
17. Tiltman A. Adenomatoid tumors of the uterus. Histopathology 1979;4:437-43.
18. Carlier M, Dardick I, Lagace A, Sreeram V. Adenomatoid tumor of the uterus: presentation in endometrial curettings. Int J Gynecol Pathol 1986;5:69-74.
19. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple- marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24:347-54.
20. Frisman D, McCarthy W, Schleiff P, Buckner S, Nocito J, O'Leary T. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations. Mod Pathol 1993;6:179-84.
21. Gaffey M, Mills S, Swanson P, Zarbo R, Shah A, Wick M. Immunoreactivity for Ber-EP4 in adenocarcinomas, adenomatoid tumors and malignant mesotheliomas. Am J Surg Pathol 1992;16:593-9.
22. Otis CN, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary ade- nocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol 1987;11:445-56.
23. Sheibani K, Shin S, Kerzirian J, Weiss L. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779-84.
24. Wick M, Loy T, Mills S, Legier J, Manivel J. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Palhol 1990;21: 759-66.
25. Latza U, Niedobitck G, Schwarting R, Nekarda H, Stein H. Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-9.
26. Nakayama K, Masuzawa H, Li S, et al. Immunohistochemical analysis of the peritoneum adjacent to endometriotic lesions using antibodies for Ber-EP4 antigen, estrogen receptors, and progesterone receptors: implication of peritoneal metaplasia in the pathogenesis of endometriosis. Int J Gynecol Pathol 1994;13:348-58.